Brexit could lead to price rises and delayed access to over-the-counter medicines including cough medicines and throat sweets, the drug industry has warned.
The Proprietary Association of Great Britain (PAGB) said its members, which include pharmaceutical giants GSK and Pfizer, expect to be hit with extra costs in excess of £1m as a result of leaving the EU.
The Proprietary Association of Great Britain (PAGB) said its members, which include pharmaceutical giants GSK and Pfizer, expect to be hit with extra costs in excess of £1m as a result of leaving the EU.
